NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,698.00
-17.00 (-0.99%)
At close: Oct 2, 2025

NGeneBio Revenue

NGeneBio had revenue of 1.85B KRW in the quarter ending June 30, 2025, a decrease of -8.93%. This brings the company's revenue in the last twelve months to 6.63B, up 32.68% year-over-year. In the year 2024, NGeneBio had annual revenue of 5.69B with 30.80% growth.

Revenue (ttm)
6.63B
Revenue Growth
+32.68%
P/S Ratio
6.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
42.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.69B1.34B30.80%
Dec 31, 20234.35B-6.67B-60.51%
Dec 31, 202211.02B3.85B53.81%
Dec 31, 20217.16B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition